TBK1 (TANK-binding kinase 1) is a serine/threonine kinase that plays central roles in innate immunity, autophagy, and cell survival. TBK1 is a critical regulator of type I interferon (IFN) signaling and selective autophagy, particularly mitophagy. Mutations in TBK1 cause a spectrum of neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and hereditary spastic paraplegia (HSP), establishing TBK1 as an important therapeutic target.
TBK1 is a 729-amino acid serine/threonine kinase that belongs to the IκB kinase (IKK) family. Originally characterized as a kinase activating NF-κB in response to tumor necrosis factor, TBK1 has emerged as a master regulator of multiple signaling pathways. The discovery of TBK1 mutations in ALS and FTD patients highlighted its importance in neuronal homeostasis. This comprehensive page covers TBK1's structure, normal functions, disease mechanisms, and therapeutic implications.
{{Infobox .infobox .infobox-protein
| protein_name = TBK1 Protein
| gene = TBK1
| uniprot_id = Q9UHD2
| molecular_weight | ~84 kDa
| localization | Cytoplasm, endosomes, mitochondria
| family = IκB kinase (IKK) family, serine/threonine kinases
}}
TBK1 contains multiple functional domains:
Kinase domain (KD, residues 1-307): The catalytic domain at the N-terminus with serine/threonine kinase activity. Contains the activation loop with critical phosphorylation sites (S172).
Ubiquitin-like domain (ULD, residues 310-390): A helical domain that participates in dimerization and substrate recognition.
Coiled-coil domain (CCD, residues 400-510): Mediates protein-protein interactions and dimerization.
**Leucine zipper (LZ, residues 515-600): Another dimerization motif.
**C-terminal scaffold dimerization domain (CSD, residues 610-729): Enables higher-order oligomerization and activation.
TBK1 exists as a dimer in solution. Activation requires:
TBK1 is essential for antiviral immunity:
TBK1 phosphorylates and activates autophagy receptors:
Over 150 TBK1 mutations have been identified in ALS/FTD:
Impaired mitophagy:
Dysregulated innate immune signaling:
Synaptic dysfunction:
Autophagy defects:
The study of Tbk1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Cirulli ET, Lasseigne BN, Petrovski S, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436-1441. PMID:25600150
Freischmidt A, Wieland T, Müller K, et al. Haploinsufficiency of TBK1 causes familial ALS and FTD. Nature Neuroscience. 2015;18(5):631-636. PMID:25803835
Xu D, Jin T, Wang H, et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in disease. Cell. 2021;184(11):3163-3178.e21. PMID:34048706
Ito Y, Honda A, Horie T. TBK1, a multi-functional kinase: from autophagy to neurodegenerative diseases. Journal of Biochemistry. 2021;169(5):527-536. PMID:33351978
Oakes JA, Davies MC, Collins MO. TBK1: a new player in ALS pathogenesis. Neurobiology of Disease. 2017;99:117-124. PMID:28069493
Ryan T, Bhowmik A, Moss S. Altered innate immune and neuronal function in TBK1-deficient models. Autophagy. 2022;18(5):1193-1196. PMID:34668816
Moore AS, Holzbaur EL. Spatiotemporal dynamics of autophagy receptors in selective mitophagy. Autophagy. 2016;12(10):1956-1957. PMID:27532861
Richter B, Sliter DA, Herhaus L, et al. Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria. Proceedings of the National Academy of Sciences. 2016;113(17):4039-4048. PMID:27091970
Wang Z, Liu J, Liu H, Chen S. TBK1 in the pathophysiology of ALS and FTD. Frontiers in Molecular Neuroscience. 2021;14:752028. PMID:34712139
van Wijk SJ, Fiskin E, Bakkar M, et al. A phospho-switch controls the dynamic association of optineurin with autophagosomes. Journal of Cell Biology. 2022;221(5):e202109001. PMID:35357456